Heron Therapeutics Q3 Revenue Falls 7.8%; to Sell Assets to CorMedix
Heron Therapeutics reported a 7.8% decline in third-quarter net revenue and plans to sell all its assets to CorMedix.
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…